| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.44 | 0.02 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.37 | 0.02 |